- Report
- September 2025
- 419 Pages
Global
From €6109EUR$6,995USD£5,307GBP
- Report
- September 2025
- 494 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- May 2025
- 740 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- January 2025
- 180 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- May 2025
- 207 Pages
Global
From €2183EUR$2,500USD£1,897GBP
- Report
- April 2025
- 400 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- February 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- January 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 182 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 197 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 195 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 185 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 185 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 195 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 181 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- April 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- January 2025
- 182 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- September 2025
- 191 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 194 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 174 Pages
Global
From €5109EUR$5,850USD£4,438GBP

Immunofluorescence is a technique used in In Vitro Diagnostics (IVD) to detect the presence of antigens in a sample. It is based on the principle of fluorescent labeling, where a fluorescent dye is used to bind to a specific antigen. The antigen-dye complex is then detected using a fluorescence microscope. Immunofluorescence is used in a variety of IVD applications, including the diagnosis of infectious diseases, autoimmune diseases, and cancer. It is also used to detect the presence of antibodies in a sample, which can be used to diagnose allergies and autoimmune diseases.
The Immunofluorescence market is a rapidly growing segment of the IVD market, driven by the increasing demand for accurate and reliable diagnostic tests. The market is expected to benefit from the development of new technologies, such as multiplexing, which allow for the simultaneous detection of multiple antigens in a single sample.
Some companies in the Immunofluorescence market include Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Agilent Technologies, and PerkinElmer. Show Less Read more